Attitudes and Intentions of Health Personnel towards Covid-19 Vaccination in Kaziba Health Zone
Abstract:
Introduction: SARS-CoV-2 is a virus
of the coronavidae family and of the beta coronavirus group, such as those responsible
for SARS and MERS. This Covid-19 is more contagious than SARS and MERS but with
a lower death rate. Covid-19 vaccine is a pharmaceutical tool to control the transmission
of Covid-19 among the health personnel and the general population. The acceptance
of Covid-19 vaccination remains reluctant among the health personnel. The purposes
of this study are to determine the intentions and attitudes of health personnel
vis-à-vis to Covid-19 vaccination and, to determine the reasons for accepting and
refusing Covid-19 vaccination among health personnel in Kaziba Health Zone from
15 to 28 July 2021. Material and methods: our study was descriptive retrospective
cross-sectional study. A random sampling method was carried out to collect the data
through survey questionnaire with 102 health personnel. The data was analyzed
with SPSS and Chi-square test was carried out. Results: the intentions and attitudes
of the health personnel vis-à-vis to Covid-19 vaccination was (31.4%), and the participants
who declared the mandatory Covid-19 vaccination was 31.4%. The health personnel
who accepted the covid-19 vaccine were 21.6%, however, those who refused was 45.1%.
Conclusion: health personnel do not have acceptable intentions and attitudes towards
Covid-19 vaccination. Only nurses and midwives, physicians and healthcare assistance
staff were agreeable to Covid-19 vaccination to control the pandemic. Lack of information
was the main refusal reason for Covid-19 vaccination. The health personnel were
not willingly too mandatory Covid-19 vaccination.
References:
[1] Banerjee, A., Kulcsar, K., Misra, V., Frieman,
M., & Mossman, K., 2019, Bats and Coronaviruses. Viruses, 11(1),
41. https://doi.org/10.3390/v11010041.
[2] WHO. (2020, February 12). Covid-19 Public Health
Emergency of International Concern (PHEIC) Global Research and Innovation Forum.
Retrieved August 9, 2021, from https://www.who.int/publications/m/item/covid-19-public-health-emergency-of-international-concern-(pheic)-global-research-and-innovation-forum.
[3] CDC. (2021, August 17). Benefits of Getting
a Covid-19 Vaccine. Centers for Disease Control and Prevention. Retrieved September
9, 2021, from https://www.cdc.gov/coronavirus/2019-ncov/vaccines/vaccine-benefits.html.
[4] Yang,
J., Marziano, V., Deng, X., Guzzetta, G., Zhang, J., Trentini, F., Cai, J., Poletti,
P., Zheng, W., Wang, W., Wu, Q., Zhao, Z., Dong, K., Zhong, G., Viboud, C., Merler,
S., Ajelli, M., & Yu, H., 2021, To what extent do we need to rely on non-pharmaceutical
interventions while Covid-19 vaccines roll out in 2021? MedRxiv, 12. https://doi.org/10.1101/2021.02.03.21251108.
[5] Wang, B., & Ping, Y., 2022, A comparative
analysis of Covid-19 vaccination certificates in 12 countries/regions around the
world: Rationalizing health policies for international travel and domestic social
activities during the pandemic. Health Policy, 126(8), 755–762. https://doi.org/10.1016/j.healthpol.2022.05.016.
[6] WHO. (2021, April 19). Statement on the seventh
meeting of the International Health Regulations (2005) Emergency Committee regarding
the coronavirus disease (Covid-19) pandemic. Retrieved August 27, 2021, from https://www.who.int/news/item/19-04-2021-statement-on-the-seventh-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic.
[7] WHO. (2020, November 13).
Feuille de route du SAGE de l’OMS pour l’établissement des priorités concernant
l’utilisation des vaccins anti-Covid-19 dans un contexte d’approvisionnement limité.
Retrieved August 31, 2021, from
https://www.who.int/fr/publications/m/item/who-sage-roadmap-for-prioritizing-uses-of-covid-19-vaccines-in-the-context-of-limited-supply.
[8]
Africa Centres for Disease Control and Prevention.
(2021, August 24). Concerns about Capacity
and Capability of Africa’s Public Health Institutions. Retrieved
21–08-30, from https://africacdc.org/.
[9] WHO. (2020a, June 29). Chronologie
de l’action de l’OMS face à la Covid-19. Retrieved August 15, 2021, from https://www.who.int/fr/news/item/29-06-2020-covidtimeline.
[10] Voysey, M., Costa Clemens, S. A., Madhi, S.
A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas,
S. L., Bhorat, Q. E., Bibi, S., Briner, C., Cicconi, P., Clutterbuck, E. A., Collins,
A. M., Cutland, C. L., Darton, T. C., Dheda, K., Dold, C, Zuidewind, P., 2021, Single-dose
administration and the influence of the timing of the booster dose on immunogenicity
and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomized
trials. The Lancet, 397(10277), 881–891. https://doi.org/10.1016/s0140-6736(21)00432-3.
[11] Chan,
J. F. W., Lau, S. K. P., To, K. K. W., Cheng, V. C. C., Woo, P. C. Y., & Yuen,
K. Y., 2015, Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus
Causing SARS-Like Disease. Clinical Microbiology Reviews, 28(2), 465–522.
https://doi.org/10.1128/cmr.00102-14.
[12] Shim, E., Tariq, A., Choi, W., Lee, Y., &
Chowell, G., 2020, Transmission potential and severity of Covid-19 in South Korea.
International Journal of Infectious Diseases, 93, 339–344. https://doi.org/10.1016/j.ijid.2020.03.031.
[13] Boseley, S., & Oltermann, P., 2020, Hopes
rise for end of pandemic as Pfizer says vaccine has 90% efficacy. The Guardian.
Retrieved July 31, 2021, from https://www.theguardian.com/world/2020/nov/09/covid-19-vaccine-candidate-effective-pfizer-biontech.
[14] Ledda, C., Costantino, C., Cuccia, M., Maltezou,
H. C., & Rapisarda, V., 2021, Attitudes of Healthcare Personnel towards Vaccinations
before and during the Covid-19 Pandemic. International Journal of Environmental
Research and Public Health, 18(5), 2703. https://doi.org/10.3390/ijerph18052703.
[15] Detoc, M., Bruel, S., Frappe, P., Tardy, B.,
Botelho-Nevers, E., & Gagneux-Brunon, A., 2020, Intention to participate in
a Covid-19 vaccine clinical trial and to get vaccinated against Covid-19 in France
during the pandemic. Vaccine, 38(45), 7002–7006. https://doi.org/10.1016/j.vaccine.2020.09.041.
[16] Loomba, S., de Figueiredo, A., Piatek, S. J.,
de Graaf, K., & Larson, H. J., 2021, Measuring the impact of Covid-19 vaccine
misinformation on vaccination intent in the UK and USA. Nature Human Behaviour,
5(3), 337–348. https://doi.org/10.1038/s41562-021-01056-1.
[17] Nachega, J. B., Sam-Agudu, N. A., Masekela,
R., van der Zalm, M. M., Nsanzimana, S., Condo, J., Ntoumi, F., Rabie, H., Kruger,
M., Wiysonge, C. S., Ditekemena, J. D., Chirimwami, R. B., Ntakwinja, M., Mukwege,
D. M., Noormahomed, E., Paleker, M., Mahomed, H., Tamfum, J. J. M., Zumla, A., &
Suleman, F., 2021, Addressing challenges to rolling out Covid-19 vaccines in African
countries. The Lancet Global Health, 9(6), e746–e748. https://doi.org/10.1016/s2214-109x(21)00097-8.
[18] Riccò, M., Ferraro, P., Peruzzi, S., Balzarini,
F., & Ranzieri, S., 2021, Mandate or Not Mandate: Knowledge, Attitudes, and
Practices of Italian Occupational Physicians towards SARS-CoV-2 Immunization at
the Beginning of Vaccination Campaign. Vaccines, 9(8), 1–16. https://doi.org/10.3390/vaccines9080889.
[19]
Halbrook, M., Martin-Blais, R., Gray, A., Tobin, N. H., Ferbas,
K. G., Aldrovandi, G. M., & Rimoin, A. W., 2021, Cross-sectional Assessment
of Covid-19 Vaccine Acceptance among Health Care Workers in Los Angeles. Annals
of Internal Medicine. https://doi.org/10.7326/m20-7580.
[20]
Verger, P., Scronias, D., Dauby, N., Adedzi, K. A., Gobert,
C., Bergeat, M., Gagneur, A., & Dubé, E., 2021, Attitudes of healthcare workers
towards Covid-19 vaccination: a survey in France and French-speaking parts of Belgium
and Canada, 2020. Eurosurveillance, 26(3). https://doi.org/10.2807/1560-7917.es.2021.26.3.2002047.
[21]
Kose, S., Mandiracioglu, A., Sahin, S., Kaynar, T., Karbus,
O., & Ozbel, Y., 2020, Vaccine hesitancy
of the Covid‐19 by health care personnel. International Journal of Clinical Practice,
75(5), 1–4. https://doi.org/10.1111/ijcp.13917.
[22]
Helmy, Y. A., Fawzy, M., Elaswad, A., Sobieh, A., Kenney, S.
P., & Shehata, A. A., 2020, The Covid-19 Pandemic: A Comprehensive Review of
Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control. Journal
of Clinical Medicine, 9(125), 22.
[23]
Castaneda-Vasquez, D. E., & Ruiz-Padilla, J. P., 2021, Vaccine
Hesitancy against SARS-CoV-2 in Health Personnel of Northeastern Mexico and Its
Determinants. JOEM, 63(8), 4.
[24]
Khamis, F., Badahdah, A., al Mahyijari, N., al Lawati, F., al
Noamani, J., al Salmi, I., & al Bahrani, M., 2021, Attitudes towards Covid-19
Vaccine: A Survey of Health Care Workers in Oman. Journal of Epidemiology and
Global Health, 12(1), 1–6. https://doi.org/10.1007/s44197-021-00018-0.
[25]
Adane, M., Ademas, A., & Kloos, H., 2022, Knowledge, attitudes,
and perceptions of Covid-19 vaccine and refusal to receive Covid-19 vaccine among
healthcare workers in northeastern Ethiopia. BMC Public Health, 22(1),
1–12. https://doi.org/10.1186/s12889-021-12362-8.